NCT01779063

Brief Summary

Lymphedema is a chronic condition that causes physical and emotional challenges to breast cancer survivors. As a progressive condition, lymphedema can result in swelling/fibrosis that can impair function, promote infection, and cause discomfort and emotional distress. Daily self-care that is required to manage lymphedema is time-consuming, burdensome, and lifelong. Previous studies found that about half of breast cancer survivors with lymphedema do not complete self-care as directed. Feelings of being helpless to manage the condition, a desire to be normal, lack of noticeable results from self-care, and poor social/healthcare professional support are barriers to performing self-care on a regular basis. There is a need to develop and test interventions to promote effective self-care. Experts suggest the best self-care interventions should include patient perspectives and be available a readily accessible format. Technological advancements support use of innovative, creative approaches, such as Web-based multimedia interventions. Web-based interventions can be used in rural and urban settings. The investigators are proposing to develop a Web-based, multimedia intervention and a "take home" manual to support self-care in breast cancer survivors with lymphedema. The investigators plan to conduct focus groups with these survivors to determine the content and delivery format(s) and to help us identify breast cancer survivors with lymphedema for the video component. The investigators will then develop an intervention that will include self-care demonstrations and other supportive information to help patients to cope with the challenges of self-care. The focus groups will reconvene, review the intervention, and give us feedback on modifying and refining the intervention. After finalizing the intervention, The investigators will recruit more breast cancer survivors with lymphedema and provide one half of them an education booklet and the other half the Web-based intervention (or an alternative format such as DVD). Then, over 12 months, the investigators will periodically assess and compare both groups on self-care behaviors, physical and emotional concerns, and other issues such as money spent on lymphedema treatment. The group that receives the education booklet will be given access to the Web-based intervention after the 12 month follow-up is done, but the investigators will not ask them to complete any more forms. This project builds upon the investigators prior work that has provided information about lymphedema self-care problems and the investigators previous experience in developing patient education videos and manuals. By providing accessible, detailed self-care instructions and a psychosocial component, this intervention has the potential to improve lymphedema self-care. If successful, this intervention can be offered to the larger national and international community of breast cancer survivors with lymphedema.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 30, 2013

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 10, 2017

Status Verified

April 1, 2017

Enrollment Period

3.9 years

First QC Date

January 23, 2013

Last Update Submit

April 7, 2017

Conditions

Keywords

lymphedemaself-carebreast cancer

Outcome Measures

Primary Outcomes (3)

  • symptom burden

    self-report of symptoms will be documented on study instruments

    change between baseline and 1, 3, 6, and 12 months post-intervention

  • function

    Self-report functional data using a validated instrument

    change between baseline and 1, 3, 6, and 12 months post-intervention

  • psychological well-being

    self-report using a validated instrument

    change between baseline and 1, 3, 6, and 12 months post-intervention

Secondary Outcomes (6)

  • coping

    change between baseline and 1, 3, 6, and 12 months post-intervention

  • self-care activities

    Change between baseline 1, 3, 6, and 12 months post-intervention

  • stress

    change between baseline and 1, 3, 6, and 12 months post-intervention

  • self-efficacy

    change between baseline and 1, 3, 6, and 12 months post-intervention

  • social support

    change between baseline and 1, 3, 6, and 12 months post-intervention

  • +1 more secondary outcomes

Study Arms (2)

web based multimedia intervention

EXPERIMENTAL

interactive,web based multimedia intervention

Behavioral: web based multimedia intervention

education booklet

ACTIVE COMPARATOR

printed educational booklet

Other: educational booklet

Interventions

cognitive therapy based web intervention

web based multimedia intervention

patient education booklet

education booklet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a history of breast cancer;
  • previous diagnosis of lymphedema;
  • Stage II lymphedema based upon International Society of Lymphedema (the limb is firm in places, elevation does not reduce swelling, it may or may not pit with pressure, and skin changes may be noted);
  • be age 18 or older;
  • be able to see and read printed documents in English; and for stage 2 only,
  • have access to the Internet or a smart phone.

You may not qualify if:

  • undergoing chemotherapy or radiation, or

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt Univeristy School of Nursing

Nashville, Tennessee, 37072, United States

Location

MeSH Terms

Conditions

LymphedemaBreast Neoplasms

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • sheila h ridner, Phd

    Vanderbilt University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 23, 2013

First Posted

January 30, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

April 10, 2017

Record last verified: 2017-04

Locations